Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 61 to 75 of 75 results for menopause

  1. Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous thromboembolism (VTE)?

    indicated. Source guidance details Comes from guidance Menopause: diagnosis and management Number NG23 Date issued

  2. Premature ovarian insufficiency:- What are the main clinical manifestations of premature ovarian insufficiency and the short- and long-term impact of the most common therapeutic interventions?

    Women with premature ovarian insufficiency can experience the effects of menopause for most of their adult life. This can lead to...

  3. Women with breast cancer:- What is the safety and effectiveness of alternatives to systemic HRT as treatments for menopausal symptoms in women who have had treatment for breast cancer?

    treatment. Source guidance details Comes from guidance Menopause: diagnosis and management Number NG23 Date issued

  4. Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset (NG16)

    This guideline covers mid-life approaches to delay or prevent the onset of dementia, disability and frailty in later life. The guideline aims to increase the amount of time that people can be independent, healthy and active in later life.

  5. Press and media

    people at risk. Menopause Most women experience some symptoms with menopause. The depletion of oestrogen associated with...

  6. Obesity prevention (CG43)

    This guideline covers preventing children, young people and adults becoming overweight or obese. It outlines how the NHS, local authorities, early years’ settings, schools and workplaces can increase physical activity levels and make dietary improvements among their target populations.

  7. Ovarian cancer (QS18)

    This quality standard covers the recognition and initial management of ovarian cancer. It describes high-quality care in priority areas for improvement.

  8. Estetrol for treating vasomotor symptoms associated with the menopause in people aged 40 to 65 ID4037

    Awaiting development [GID-TA11059] Expected publication date: TBC

  9. Peezy Midstream for urine collection (MT446)

    In development [GID-MT538] Expected publication date: TBC

  10. Fezolinetant for treating vasomotor symptoms associated with the menopause [ID5071]

    In development [GID-TA11058] Expected publication date: TBC

  11. Elinzanetant for treating vasomotor symptoms associated with menopause TS ID 11917

    Awaiting development [GID-TA11428] Expected publication date: TBC

  12. Menopause

    All NICE products on menopause. Includes any guidance and quality standards.

  13. Women's and reproductive health guidelines

    complications and their babies - Breech presenting in labour Menopause: diagnosis and management Update in progress: Major update...

  14. Menopause: diagnosis and management

    In development [GID-NG10241] Expected publication date: TBC